Page 1 of Clinical Trials for Drug Octreotide-LAR, 35 Total Matches
- 1RecruitingLast Updated: August 18, 2010Condition(s): Acromegaly
- 2CompletedLast Updated: June 27, 2011Condition(s): Chemotherapy-induced Diarrhea
- 3RecruitingLast Updated: November 14, 2011Condition(s): Acromegaly
- 4Active, not recruitingLast Updated: September 19, 2011Condition(s): Acromegaly
- 5CompletedLast Updated: July 20, 2011Condition(s): Pituitary Adenoma
- 6CompletedLast Updated: December 3, 2007Condition(s): Type 2 Hepatorenal Syndrome; Refractory Ascites
- 7RecruitingLast Updated: May 19, 2011Condition(s): Symptomatic Refractory Resistant Carcinoid Disease
- 8Active, not recruitingLast Updated: July 5, 2011Condition(s): Polycystic Kidney, Autosomal Dominant; Hepatomegaly; Liver Diseases; Kidney, Polycystic; Abdominal Pain
- 9CompletedLast Updated: April 13, 2007Condition(s): Acromegaly
- 10Completed
- 11CompletedLast Updated: February 16, 2011Condition(s): Acromegaly
- 12RecruitingLast Updated: September 15, 2010Condition(s): Neuroendocrine Carcinomas
- 13Active, not recruitingLast Updated: June 20, 2011Condition(s): Autosomal Dominant Polycystic Kidney Disease.
- 14CompletedLast Updated: October 6, 2009Condition(s): Respiratory Tract Neoplasms; Thymic Neoplasms; Pancreatic Neoplasms; Gastrointestinal Neoplasms; Multiple Endocrine Neoplasia
- 15CompletedLast Updated: March 22, 2011Condition(s): Neuroendocrine Carcinoma; Islet Cell Carcinoma
- 16Active, not recruitingLast Updated: August 3, 2011Condition(s): Neuroendocrine Tumors
- 17RecruitingLast Updated: November 29, 2011Condition(s): Acromegaly
- 18CompletedLast Updated: September 20, 2011Condition(s): Peritoneal Neoplasms; Intestinal Obstruction; Carcinomatosis
- 19CompletedLast Updated: October 11, 2007Condition(s): Acromegaly
- 20RecruitingLast Updated: July 6, 2010Condition(s): Polycystic Liver Disease
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Octreotide-LAR
